Drug intelligence / Profile preview

jiechangyan shuan

Development stage
Unknown
Lead developer
Jinan Kangzhong Pharmaceutical Technology Development
Modality
Small Molecules
Administration
Rectal
01

Overview

Jiechangyan Shuan is a Traditional Chinese Medicine (TCM) suppository developed for the treatment of ulcerative colitis and chronic proctitis. It is a multi-herbal formulation containing extracts from Sophorae Flavescentis Radix, Sanguisorbae Radix, Galla Chinensis, Indigo Naturalis, Bletillae Rhizoma, and Corydalis Rhizoma. The medication is designed for rectal administration, allowing for high local concentrations of active constituents at the site of colonic inflammation. Its primary mechanism of action involves the inhibition of pro-inflammatory cytokines (such as TNF-α and IL-6) and the modulation of the NF-κB signaling pathway, which reduces mucosal inflammation and promotes the healing of intestinal ulcers. Jinan Kangzhong Pharmaceutical Technology Development Co., Ltd. is a key developer of this formulation, which is widely manufactured and marketed in China for gastrointestinal disorders.

Brand names
Jiechangyan Shuan
Other names
Colitis SuppositoryJie Chang Yan Shuan
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κB

Beyond the preview

Go deeper on jiechangyan shuan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on jiechangyan shuan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call